Cargando…

Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus

BACKGROUND & AIMS: Esophageal adenocarcinoma (EAC) develops from its precursor Barrett’s esophagus through intermediate stages of low- and high-grade dysplasia. However, knowledge of genetic drivers and molecular mechanisms implicated in disease progression is limited. Herein, we investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gotovac, Jovana R., Kader, Tanjina, Milne, Julia V., Fujihara, Kenji M., Lara-Gonzalez, Luis E., Gorringe, Kylie L., Kalimuthu, Sangeetha N., Jayawardana, Madawa W., Duong, Cuong P., Phillips, Wayne A., Clemons, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267443/
https://www.ncbi.nlm.nih.gov/pubmed/33774196
http://dx.doi.org/10.1016/j.jcmgh.2021.03.008
_version_ 1783720147202080768
author Gotovac, Jovana R.
Kader, Tanjina
Milne, Julia V.
Fujihara, Kenji M.
Lara-Gonzalez, Luis E.
Gorringe, Kylie L.
Kalimuthu, Sangeetha N.
Jayawardana, Madawa W.
Duong, Cuong P.
Phillips, Wayne A.
Clemons, Nicholas J.
author_facet Gotovac, Jovana R.
Kader, Tanjina
Milne, Julia V.
Fujihara, Kenji M.
Lara-Gonzalez, Luis E.
Gorringe, Kylie L.
Kalimuthu, Sangeetha N.
Jayawardana, Madawa W.
Duong, Cuong P.
Phillips, Wayne A.
Clemons, Nicholas J.
author_sort Gotovac, Jovana R.
collection PubMed
description BACKGROUND & AIMS: Esophageal adenocarcinoma (EAC) develops from its precursor Barrett’s esophagus through intermediate stages of low- and high-grade dysplasia. However, knowledge of genetic drivers and molecular mechanisms implicated in disease progression is limited. Herein, we investigated the effect of Mothers against decapentaplegic homolog 4 (SMAD4) loss on transforming growth factor β (TGF-β) signaling functionality and in vivo tumorigenicity in high-grade dysplastic Barrett’s cells. METHODS: An in vivo xenograft model was used to test tumorigenicity of SMAD4 knockdown or knockout in CP-B high-grade dysplastic Barrett’s cells. RT(2) polymerase chain reaction arrays were used to analyze TGF-β signaling functionality, and low-coverage whole-genome sequencing was performed to detect copy number alterations upon SMAD4 loss. RESULTS: We found that SMAD4 knockout significantly alters the TGF-β pathway target gene expression profile. SMAD4 knockout positively regulates potential oncogenes such as CRYAB, ACTA2, and CDC6, whereas the CDKN2A/B tumor-suppressor locus was regulated negatively. We verified that SMAD4 in combination with CDC6-CDKN2A/B or CRYAB genetic alterations in patient tumors have significant predictive value for poor prognosis. Importantly, we investigated the effect of SMAD4 inactivation in Barrett’s tumorigenesis. We found that genetic knockdown or knockout of SMAD4 was sufficient to promote tumorigenesis in dysplastic Barrett’s esophagus cells in vivo. Progression to invasive EAC was accompanied by distinctive and consistent copy number alterations in SMAD4 knockdown or knockout xenografts. CONCLUSIONS: Altogether, up-regulation of oncogenes, down-regulation of tumor-suppressor genes, and chromosomal instability within the tumors after SMAD4 loss implicates SMAD4 as a protector of genome integrity in EAC development and progression. Foremost, SMAD4 loss promotes tumorigenesis from dysplastic Barrett’s toward EAC.
format Online
Article
Text
id pubmed-8267443
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82674432021-07-16 Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus Gotovac, Jovana R. Kader, Tanjina Milne, Julia V. Fujihara, Kenji M. Lara-Gonzalez, Luis E. Gorringe, Kylie L. Kalimuthu, Sangeetha N. Jayawardana, Madawa W. Duong, Cuong P. Phillips, Wayne A. Clemons, Nicholas J. Cell Mol Gastroenterol Hepatol Original Research BACKGROUND & AIMS: Esophageal adenocarcinoma (EAC) develops from its precursor Barrett’s esophagus through intermediate stages of low- and high-grade dysplasia. However, knowledge of genetic drivers and molecular mechanisms implicated in disease progression is limited. Herein, we investigated the effect of Mothers against decapentaplegic homolog 4 (SMAD4) loss on transforming growth factor β (TGF-β) signaling functionality and in vivo tumorigenicity in high-grade dysplastic Barrett’s cells. METHODS: An in vivo xenograft model was used to test tumorigenicity of SMAD4 knockdown or knockout in CP-B high-grade dysplastic Barrett’s cells. RT(2) polymerase chain reaction arrays were used to analyze TGF-β signaling functionality, and low-coverage whole-genome sequencing was performed to detect copy number alterations upon SMAD4 loss. RESULTS: We found that SMAD4 knockout significantly alters the TGF-β pathway target gene expression profile. SMAD4 knockout positively regulates potential oncogenes such as CRYAB, ACTA2, and CDC6, whereas the CDKN2A/B tumor-suppressor locus was regulated negatively. We verified that SMAD4 in combination with CDC6-CDKN2A/B or CRYAB genetic alterations in patient tumors have significant predictive value for poor prognosis. Importantly, we investigated the effect of SMAD4 inactivation in Barrett’s tumorigenesis. We found that genetic knockdown or knockout of SMAD4 was sufficient to promote tumorigenesis in dysplastic Barrett’s esophagus cells in vivo. Progression to invasive EAC was accompanied by distinctive and consistent copy number alterations in SMAD4 knockdown or knockout xenografts. CONCLUSIONS: Altogether, up-regulation of oncogenes, down-regulation of tumor-suppressor genes, and chromosomal instability within the tumors after SMAD4 loss implicates SMAD4 as a protector of genome integrity in EAC development and progression. Foremost, SMAD4 loss promotes tumorigenesis from dysplastic Barrett’s toward EAC. Elsevier 2021-03-25 /pmc/articles/PMC8267443/ /pubmed/33774196 http://dx.doi.org/10.1016/j.jcmgh.2021.03.008 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Gotovac, Jovana R.
Kader, Tanjina
Milne, Julia V.
Fujihara, Kenji M.
Lara-Gonzalez, Luis E.
Gorringe, Kylie L.
Kalimuthu, Sangeetha N.
Jayawardana, Madawa W.
Duong, Cuong P.
Phillips, Wayne A.
Clemons, Nicholas J.
Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus
title Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus
title_full Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus
title_fullStr Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus
title_full_unstemmed Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus
title_short Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus
title_sort loss of smad4 is sufficient to promote tumorigenesis in a model of dysplastic barrett’s esophagus
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267443/
https://www.ncbi.nlm.nih.gov/pubmed/33774196
http://dx.doi.org/10.1016/j.jcmgh.2021.03.008
work_keys_str_mv AT gotovacjovanar lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus
AT kadertanjina lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus
AT milnejuliav lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus
AT fujiharakenjim lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus
AT laragonzalezluise lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus
AT gorringekyliel lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus
AT kalimuthusangeethan lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus
AT jayawardanamadawaw lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus
AT duongcuongp lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus
AT phillipswaynea lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus
AT clemonsnicholasj lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus